Patient-centered Communication About Healthy Weight in Early Breast Cancer

Breast Cancer Clinical Trial

Official title:

Clinic-based "Patient-Centered Communication About Healthy Weight" (PCC-HW) in a Diverse Sample of Women With Early Breast Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04504201
• Other study ID #: LCCC 1954
• Status: Completed
• Start date: June 15, 2020
• Est. completion date: September 29, 2020

Study information

• Verified date: July 2022
• Source: UNC Lineberger Comprehensive Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Comorbidities in breast cancer survival account for 49% of overall survival difference between black and white women. Many obesity-related comorbidities disproportionately affect black women, therefore pointing to a need to address obesity related comorbidities in survival disparities in early breast cancer patients. This study tinvestigates how messages and messaging about healthy weight can be tailored for racially diverse breast cancer survivors with obesity in order to ensure that clinic-based communications between patients and their oncology provider are patient-centered and culturally sensitive.

Description:

The overall goal of this research is to collect essential input for the future development of a quality improvement intervention to foster "Patient-Center Communication about Healthy Weigh in clinical practice

Primary Objective:

1. Understand patient-centered perspectives on health weight communication with oncology clinicians by conducting focus groups

Secondary Objective

2. Understand oncology clinician perspectives on patient center communications for healthy weight interactions through semi-structured interviews.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 39
• Est. completion date: September 29, 2020
• Est. primary completion date: September 29, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years to 99 Years

Eligibility

Inclusion Criteria for Breast Cancer Cohort:

• Age 21 or older

• Diagnosed with early breast cancer, Stages I-III

• Completed primary treatment (Surgery, chemotherapy, radiation) within past 2 years

• Body mass Index of equal or greater than 30

Exclusion Criteria:

• Cannot understand and speak English

INclusion Criteria for Oncology provider cohort:

• Breast cancer oncology provider in North Carolina with MD/DO/PA/NP/RN

• associated with community-based practices

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms

Intervention

Other:
• Focus Group
Breast cancer patients and oncology clinicians will participate in separate focus groups discussing patient-centered communication about healthy weight.

Locations

Country	Name	City	State
United States	University of North Carolina at Chapel Hill	Chapel Hill	North Carolina

Sponsors (3)

Lead Sponsor	Collaborator
UNC Lineberger Comprehensive Cancer Center	American Cancer Society, Inc., Pfizer

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feedback from patients regarding healthy weight communication through focus groups	Summary of conversation based on 5A's Behavioral Change Model	3 year
Secondary	Feedback from oncology providers regarding healthy weight communication through semi-structured interview	Provider suggestions on how to implement 5A's Behavioral change model into patient care	3 year